argenx SE (EBR:ARGX)
Belgium flag Belgium · Delayed Price · Currency is EUR
619.20
+3.40 (0.55%)
Feb 21, 2025, 5:35 PM CET

argenx SE Revenue

argenx SE had revenue of $588.88M USD in the quarter ending September 30, 2024, with 73.28% growth. This brings the company's revenue in the last twelve months to $1.91B, up 85.56% year-over-year. In the year 2023, argenx SE had annual revenue of $1.27B with 187.66% growth.

Revenue (ttm)
$1.91B
Revenue Growth
+85.56%
P/S Ratio
21.53
Revenue / Employee
$1.66M
Employees
1,148
Market Cap
37.62B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.27B827.59M187.66%
Dec 31, 2022441.01M-87.26M-16.52%
Dec 31, 2021528.27M466.31M752.59%
Dec 31, 202061.96M-30.85M-33.24%
Dec 31, 201992.81M63.58M217.51%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UCB SA 5.45B
Fagron NV 874.84M
Ion Beam Applications 465.75M
Nyxoah 5.08M
Onward Medical -188.00K
Hyloris Pharmaceuticals 6.94M
Sequana Medical NV 433.50K
Biocartis Group NV 60.82M
Revenue Rankings